From Whole-Tumor Vaccines to Personalized Peptides: Lessons from Clinical Translation

• Evolution of cancer vaccines from whole-tumor and dendritic-cell approaches to personalized peptide vaccines
• Translating personalized peptide vaccines into clinical practice across solid tumors using advanced neoantigen prediction and selection
• Integrating sophisticated immune monitoring, including next-generation TCR sequencing, to assess vaccine-induced immune responses and guide future vaccine development

Speakers:

Lana Kandalaft

Chief, Clinical & Translational Research

Swiss Medical Network